Site icon OncologyTube

Why was NINLARO compared to a placebo in TOURMALINE-MM4?

Meletios Athanasios Dimopoulos @thanosdimop of University Athens School of Medicine answers why ninlaro was compared to a placebo in TOURMALINE-MM4. Dr. Dimopoulous further discusses when the TOURMALINE-MM4 trial results will be presented.

Exit mobile version